| Ms Rebecca R Sponsler, MS CEAP LMHC | |
|
1408 East 10th St, Atlantic, IA 50022 | |
| (712) 243-2606 | |
| (712) 243-2688 |
| Full Name | Ms Rebecca R Sponsler |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 1408 East 10th St, Atlantic, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205807872 | NPI | - | NPPES |
| 00449 | Other | IA | LICENSED MENTAL HEALTH CO |
| 018549 | Other | EMPLOYEE ASSISTANCE CERTI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 00449 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Rebecca R Sponsler, MS CEAP LMHC 1408 East 10th St, Atlantic, IA 50022 Ph: (712) 243-2606 | Ms Rebecca R Sponsler, MS CEAP LMHC 1408 East 10th St, Atlantic, IA 50022 Ph: (712) 243-2606 |
News Archive
The Drugs for Neglected Diseases initiative (DNDi) has announced today at the 9th European Congress on Tropical Medicine and International Health in Basel, Switzerland, the successful completion of Phase I human clinical trials for SCYX-7158 (AN5568), the first oral drug candidate specifically developed from the earliest drug discovery stage to combat human African trypanosomiasis, or sleeping sickness, a deadly parasitic disease transmitted by the tsetse fly.
Cancer scientists led by Dr. John Dick at the Ontario Cancer Institute (OCI) and collaborators at St Jude Children's Research Hospital (Memphis) have found that defective genes and the individual leukemia cells that carry them are organized in a more complex way than previously thought.
Researchers from Denmark, Sweden, Norway and Finland (the NORDynamIC project group) have observed that depressive symptoms in patients with hepatitis C virus (HCV) infection are commonly overlooked in routine clinical interviews, and that treatment-induced depression compromises the outcome of HCV therapy. A second U.S. study found that patients with chronic infection had lower (work) productivity and incurred higher medical benefit costs than those without HCV.
Antigenics Inc. reported today its results for the quarter ended September 30, 2009. The company incurred a net loss attributable to common stockholders of $10.8 million, or $0.13 per share, basic and diluted, for the third quarter of 2009, compared with a net loss attributable to common stockholders in the third quarter of 2008 of $11.4 million, or $0.17 per share, basic and diluted.
› Verified 3 days ago
Tawna L Rutherford, TCADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1500 E 10th St, Atlantic, IA 50022 Phone: 712-243-5091 Fax: 712-243-1337 | |
Peggy Fitzwater, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2307 Olive St, Atlantic, IA 50022 Phone: 712-243-2606 | |
Taylor Beane, T-CADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 2307 Olive St, Atlantic, IA 50022 Phone: 712-243-2606 | |
Mrs. Melanie Fell, TLMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 101 E 22nd St, Atlantic, IA 50022 Phone: 712-254-9018 | |
Angela Hawkins, LHMC Counselor Medicare: Not Enrolled in Medicare Practice Location: 2307 Olive St, Atlantic, IA 50022 Phone: 712-243-2606 Fax: 712-243-1337 | |
Erin M Steffensen, CADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1500 E 10th St, Atlantic, IA 50022 Phone: 712-243-5091 Fax: 712-243-1337 | |
Celeste L Borts, TCADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 2307 Olive St, Atlantic, IA 50022 Phone: 712-243-5091 Fax: 712-243-1337 |